The placing means he's diluted his own shareholding.
However IMO he's pretty confident that he'll now have a smaller slice in a much bigger pie.
You guess. :-)
I think not. :-)
On April 6th - AVCT had a placing @ 18p.
It was to fund what was coming.
It is now @ 184p.
For info:
See page 6 of attached prospecus for SYME Major Shareholders.
https://www.supplymecapital.com/wp-content/uploads/2020/03/2020_03_04_Prospectus-posted.pdf
Open Orphan rockets! Why I think it will double your money
Tom Rodgers | Monday, 18th May, 2020
Anglo-Irish pharma firm Open Orphan (LSE:ORPH) is my choice for the next big thing in UK biopharma, and its Covid-19 test is just one string to its bow.
continues
https://www.fool.co.uk/investing/2020/05/18/open-orphan-rockets-why-i-think-it-will-double-your-money/
Actually , TW's latest free podcast summary starts with :
"I have no guests in this week's show which is sponsored by Open Orphan PLC (ORPH) where things look increasinly promising"
Where do you see the director sells?
George Stavrinidis is not a director of the company.
Correct me if I'm wrong but I'd thought a 3 bagger from 6p would be 24p, not 18p.
Price 6p
1 bagger ( doube) = 12p
2 bagger , would then be 12 + 6 = 18p
3 bagger , would then be 18 + 6 = 24p
Right or wrong? :-)
Looking at the number of articles that are now appearing wrt undertaking a Human Challenge study to test the valididty of a possible vaccine , it appears that a momentum to go ahead with these studies is building such that it would appear that it now becoming apparent that it is pretty inevitable that they will have to take place.
Obviously if this turns out to be the case , then ORPHs facilities will be in huge demand , even more so than at present.
Another very recent article :
ASU scientists searching sewers for traces of COVID-19
May 7th
The City of Tempe, AZ partnered with a university research team to test levels of SARS-CoV-2 in wastewater and identify hotspots of the virus.
Through a research partnership with the City of Tempe, AZ, Professor Rolf Halden and his team of researchers are using years-old technology to better understand the new coronavirus. Through wastewater testing, the team can identify regional levels of SARS-CoV-2 — the virus that causes COVID-19 — and identify viral hotspots in the city. That data can then be used to implement effective policies and measures to improve public health.
continues...
"Through wastewater testing, the team can identify regional levels of SARS-CoV-2 — the virus that causes COVID-19 — and identify viral hotspots in the city. That data can then be used to implement effective policies and measures to improve public health."
...
"We always learn after the fact," Halden told Smart Cities Dive when describing the need for more preventative testing. "The sooner we learn about the presence of the virus in the city, the better off we are."
hTTps://www.smartcitiesdive.com/news/asu-scientists-searching-sewers-for-traces-of-covid-19/577518/
An Australian article but I'm sure it will be similar in the UK.
Coronavirus deep clean surge sparks recruitment drive at Whizz
May 8, 2020
On-demand cleaning startup Whizz is looking to recruit 1,000 new cleaners over the next six months to meet the rising demand for specialised disinfectant and decontamination deep cleaning.
Whizz, started by Mark Bernberg, Adam Abrams and Julian Tobias in 2015, already has 1,500 cleaners on its books who operate as contractors. It turned over around $10 million last year in a sector valued at $12.8 billion in Australia and Mr Bernberg said demand had soared in response to the coronavirus outbrea
continues....
"Because of COVID-19 there are going to be lasting changes in behaviour and a higher expectation of cleanliness and the end product of a cleaning service," he said.
https://www.smh.com.au/business/small-business/coronavirus-deep-clean-surge-sparks-recruitment-drive-at-whizz-20200507-p54qsa.html
Julian Clark joins Ince as a Senior Partner
in Shipping Law News 05/05/2020
Ince is delighted to announce that Julian Clark, the former Head of Global Shipping at an international law firm, today takes up his position as the firm’s Senior Partner. He is based in London, but will take global responsibility for the firm’s practice sectors and client base, both in the UK and internationally.
Julian is an internationally recognised leader in shipping, international trade and energy dispute resolution, with over 30 years’ experience in mediation, arbitration and litigation. Across his career he has also developed further expertise in piracy, e-commerce and cybercrime, security and terrorism issues in the shipping sector.
Adrian Biles, Chief Executive of the Ince Group, said:
“I’m excited that Julian has joined Ince. He will bring industry-leading expertise to our global shipping team and his client building and management skills across all of our other practice areas. In the short term he will be working with practice groups on advising clients on critical issues in this challenging landscape. Over the coming months his experience enables us to expand our offers in cyber security and e-commerce.”
In his previous role, Julian managed the firm’s global shipping practice across its international network of offices. Before joining his old firm, he was a partner with HFW and one of the founding partners of Campbell Johnston Clark.
Julian Clark, Senior Partner, Ince added:
“It’s a great honour to be joining Ince as the Senior Partner and help the firm strengthen its position as a market leader in legal and business advice. I look forward to working with my colleagues and helping clients navigate through these challenging times.”
Source: Ince
CF has mentioned a couple of times recently that he expects a positive article to be printed about the Mosquito vaccine in the Lancet in the near future.
If this is the case it will highlight another string to ORPHs lucrative bow.
The article below written in the Times in October last year is may have something to do with it. :-)
Note: I think it's pretty much agreed that the annual royalty value mentioned was a bit over the top.
Eastern promise for Nuformix
Shares in Nuformix, the Cambridge-based drug company, gave up recent gains yesterday to trade 5 per cent lower and close at 8¼p.
Nuformix uses cocrystal technology to re-engineer the crystalline form of drugs
NUFORMIX
Chatter that Nuformix is close to securing a licensing deal with Kissei Pharmaceutical, one of Japan’s largest drug companies, has sent shares in the minnow higher in recent days.
Nuformix uses co-crystal technology to re-engineer drugs. Market gossip suggests that Kissei is in talks to license Nuformix’s lead fibrosis treatment alongside its unique oral delivery system.
The proprietary delivery mechanism resolves a number of efficacy problems that have plagued Kissei for years, they claim. The partnership could enable Kissei to treat other conditions.
The reports suggest that the deal being discussed involves an upfront milestone payment of £15 million and annual royalty payments worth more than £200 million.
If a deal is struck and structured on those terms, Nuformix would generate revenues well in excess of its current £40 million market value.
Established in 2008, Nuformix set out to identify known drug molecules with the potential to function as innovative therapies for unmet medical needs.
A coronavirus side effect: lots of lawsuits
Carnival Corp. is facing lawsuits from several passengers who claim they weren’t warned of the high risk of being infected with the novel coronavirus on the company’s cruise ships.
Wells Fargo,, Bank of America, JPMorgan Chase and US Bancorp have been sued by small businesses that missed out on coronavirus rescue loans because, the small firms contend, the banks first processed big loans that generated big fees rather than on a first-come-first-served basis.
Six Flags Magic Mountain is being sued by a theme park fan who objects to the park collecting monthly payments for his membership pass while the park is closed due to the pandemic.
continues...
https://www.latimes.com/business/story/2020-04-21/coronavirus-lawsuits-target-theme-parks-airlines-cruise-ships-others
He's on the accompanying April presentatiom.
Currently can't get a quote to buy any online.
With halifax.
For info:
Link Fund Solutions (Woodford) held c36.8m shares on 20thJan 2020.
Over 80m ORPH shares were traded in Feb.
Over 170m ORPH shares were traded in March.
Currently over 100m ORPH shares have been traded in April.
Any seller has had plenty oportunity to sell in the last few months.
Seller/s geting close to finishing?
Draw your own conclusions.
Why didn’t his last role last long at Valerie Cafe?
Don't you follow business news?
From Jan 2019.
Patisserie Valerie was forced into administration on Tuesday after it failed to reach a rescue deal with its banks.
Entrepreneur Luke Johnson, who bought the business in 2006, has committed more money to ensure staff are paid this month.
The first signs of trouble came back in October after accounting "irregularities" were announced. That included "secret overdrafts" unknown to Mr Johnson and the board.
Shares in Patisserie Holdings were suspended and finance director Chris Marsh was arrested and later released on bail without charge.